WPI 3630 (Hydromorphone Hydrochloride Extended-Release 16 mg)
Pill with imprint WPI 3630 is Yellow, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 16 mg. It is supplied by Watson Laboratories, Inc..
Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 16 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3630
Hydromorphone Hydrochloride Extended-Release
- Imprint
- WPI 3630
- Strength
- 16 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3630
More about hydromorphone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 397 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (9)
Consumer resources
- Hydromorphone
- Hydromorphone injection
- Hydromorphone rectal
- Hydromorphone Extended-Release Tablets
- Hydromorphone Tablets
- ... +4 more
Other brands: Dilaudid, Dilaudid-HP, Palladone, Exalgo
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
